Rx Pak Division of McKesson Corporation recalls Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use only, Mfg by: Aenova

Recalled March 27, 2019 · FDA recall D-1007-2019 · Rx Pak Division of McKesson

Hazard

Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps. · FDA Class II

Units

29,622 Blister Cards

Sold at

Product was distributed to 5 major distributors who may have further distributed the product throughout the United States.

Description

Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.

Product

Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use only, Mfg by: Aenova Holding GmBh, Miami, Fl 33186, NDC 63739-0478-10

Manufacturer(s)

Rx Pak Division of McKesson Corporation

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →